HeartFlow
Heartflow is rewriting the story of coronary artery disease (CAD).
Our AI-driven platform creates a 3D model of the heart, providing physicians with precise, personalized insights—identifying disease type, location, volume, severity, and its impact on function—guiding the next steps for treatment.
By transforming how CAD is understood and diagnosed, we are setting a new standard of care that empowers earlier, proactive, and more effective disease management.
Heartflow
See CAD. Manage for life.
Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com
Video Player is loading.
10 seconds
Playback speed
Informing cath lab planning and treatment with CCTA and FFRCT
Dr. Ziad A. Ali moderates a discussion with Dr. Michael Nanna and Dr. Glen Fandetti regarding:
- The application of CCTA & FFRCT clinical evidence for the Interventional Cardiologist
- How to leverage CCTA & FFRCT for the Cath Lab
Comments 0
Login to view comments.
Click here to Login
